Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.51B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.02B |
| 3 |
Oracle
ORCL
|
+$895M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$854M |
| 5 |
S&P Global
SPGI
|
+$827M |
Top Sells
| 1 |
Intel
INTC
|
+$1.22B |
| 2 |
Constellation Brands
STZ
|
+$870M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$852M |
| 4 |
Carvana
CVNA
|
+$805M |
| 5 |
Bank of America
BAC
|
+$750M |
Sector Composition
| 1 | Technology | 20.58% |
| 2 | Financials | 12.02% |
| 3 | Consumer Discretionary | 8.72% |
| 4 | Healthcare | 8.7% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4951
iPath Select MLP ETN
ATMP
$509M
| $862K | ﹤0.01% |
28,118
-20,953
| -43% | -$642K |
|
|
CRON
4952
Cronos Group
CRON
$1.01B
| $862K | ﹤0.01% |
476,119
+129,423
| +37% | +$234K |
|
4953
IO Biotech
IOBT
$109M
| $861K | ﹤0.01% |
789,461
-69,714
| -8% | -$76K |
|
4954
Nkarta
NKTX
$138M
| $860K | ﹤0.01% |
467,481
-1,286,863
| -73% | -$2.37M |
|
|
VENU
4955
Venu Holding Corporation
VENU
$555M
| $859K | ﹤0.01% |
+92,823
| New | +$859K |
|
4956
Health Catalyst
HCAT
$204M
| $856K | ﹤0.01% |
189,026
-66,266
| -26% | -$300K |
|
|
CEV
4957
Eaton Vance California Municipal Income Trust
CEV
$70.5M
| $856K | ﹤0.01% |
85,419
+4,125
| +5% | +$41.3K |
|
4958
Neumora Therapeutics
NMRA
$243M
| $852K | ﹤0.01% |
852,372
+120,960
| +17% | +$121K |
|
4959
Dimensional International High Profitability ETF
DIHP
$4.52B
| $850K | ﹤0.01% |
31,568
+3,482
| +12% | +$93.8K |
|
|
DOYU
4960
DouYu International Holdings
DOYU
$232M
| $850K | ﹤0.01% |
113,759
+85,933
| +309% | +$642K |
|
4961
Angel Oak Income ETF
CARY
$638M
| $847K | ﹤0.01% |
40,799
+40,759
| +101,898% | +$846K |
|
|
MBX
4962
MBX Biosciences, Inc. Common Stock
MBX
$343M
| $846K | ﹤0.01% |
114,610
+90,775
| +381% | +$670K |
|
|
BITF
4963
Bitfarms
BITF
$1.81B
| $846K | ﹤0.01% |
1,073,091
-1,769,444
| -62% | -$1.39M |
|
4964
First Trust Dividend Strength ETF
FTDS
$27.8M
| $841K | ﹤0.01% |
16,521
+122
| +0.7% | +$6.21K |
|
4965
Xilio Therapeutics
XLO
$39.1M
| $837K | ﹤0.01% |
1,155,838
+154,479
| +15% | +$112K |
|
4966
Global X MSCI Greece ETF
GREK
$308M
| $833K | ﹤0.01% |
17,739
-7,174
| -29% | -$337K |
|
4967
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund
TLTE
$293M
| $833K | ﹤0.01% |
15,873
-495
| -3% | -$26K |
|
4968
Flexsteel Industries
FLXS
$258M
| $832K | ﹤0.01% |
22,801
+3,754
| +20% | +$137K |
|
4969
Superior Group of Companies
SGC
$189M
| $830K | ﹤0.01% |
75,910
-28,077
| -27% | -$307K |
|
4970
iShares MSCI China A ETF
CNYA
$216M
| $829K | ﹤0.01% |
29,578
+678
| +2% | +$19K |
|
4971
FT Vest Fund of Buffer ETFs
BUFR
$7.5B
| $827K | ﹤0.01% |
27,871
+2,034
| +8% | +$60.4K |
|
4972
Fulcrum Therapeutics
FULC
$404M
| $823K | ﹤0.01% |
285,599
-1,246,133
| -81% | -$3.59M |
|
4973
Open Lending Corp
LPRO
$261M
| $819K | ﹤0.01% |
296,772
-141,476
| -32% | -$390K |
|
4974
TScan Therapeutics
TCRX
$95.3M
| $818K | ﹤0.01% |
592,970
+180,112
| +44% | +$249K |
|
4975
VTEX
VTEX
$837M
| $816K | ﹤0.01% |
160,986
-54,339
| -25% | -$275K |
|